MarketPeel
Insider Trading Intelligence
RR

Raul R. Rodriguez

RIGL
CEO, PRESIDENT · RIGEL PHARMACEUTICALS INC · CIK 0001190279
FILING MIX · LIFETIME67%/33%
BUYS
28
SELLS
14
TOTAL VALUE
$10.51M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
31,700
AVG SELL PX
$21.50
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Raul R. Rodriguez, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%+5.06%-0.73%+5.79%+0.51%
14d6+83.33%+6.47%-0.51%+6.98%-2.80%
30d6+50.00%+23.92%-1.30%+25.22%+16.33%
60d6+66.67%+10.81%-2.94%+13.76%+1.55%
90d6+66.67%+7.82%-0.84%+8.66%-1.96%
180d6+83.33%-2.76%+6.63%-9.38%-12.42%
1y6+33.33%+62.81%+17.53%+45.28%+53.86%
2y6(2 pending)+25.00%+120.13%+43.31%+76.82%+76.16%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RIGL · 31,700 shares · as of Jun 17, 2026
0522,3811,044,7621,567,1422,089,523202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 28 buys / 14 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
31,70031,700Jun 17, 2026Jun 22, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
2,424$29.86$72.4K279,593Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
53,915282,017Feb 17, 2026Feb 19, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
7,607$34.62$263.4K228,102Feb 10, 2026Feb 12, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
14,110$36.01$508.1K235,709Feb 2, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
40,0000Jan 26, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
CEO, President
40,000$27.40$1.10M285,243Jan 26, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
35,211$37.00$1.30M245,243Jan 26, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
35,424$37.00$1.31M249,819Jan 26, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
CEO, President
40,000$27.40$1.10M280,454Jan 26, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
31,70031,700Sep 15, 2025Sep 17, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
26,25026,250Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00030,000Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
4,400$21.93$96.5K239,454Feb 5, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
4,952$20.92$103.6K243,854Feb 4, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
63,40063,400Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
42,300248,806Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
CEO, President
45,000$21.40$963.0K250,584Jan 24, 2025Jan 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
44,078$22.17$977.2K206,506Jan 24, 2025Jan 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
CEO, President
45,000$21.40$963.0K249,662Jan 24, 2025Jan 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
44,078$22.17$977.2K205,584Jan 24, 2025Jan 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
45,0000Jan 24, 2025Jan 28, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00030,000Nov 25, 2024Nov 26, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
32,50032,500Aug 30, 2024Sep 4, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
300,000300,000Feb 28, 2024Mar 1, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
30,545$1.14$34.8K2,036,629Feb 5, 2024Feb 6, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
22,349$1.13$25.3K2,067,174Feb 2, 2024Feb 6, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
400,0002,089,523Jan 23, 2024Jan 25, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
600,000600,000Jan 23, 2024Jan 25, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
CEO, President
20,340$1.75$35.6K1,680,713Feb 6, 2023Feb 7, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
600,000600,000Jan 26, 2023Feb 7, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
300,0001,701,053Jan 26, 2023Feb 7, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
200,000400,000Jan 26, 2023Jan 30, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
200,000200,000Dec 28, 2022Dec 30, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
300,000300,000Sep 14, 2022Sep 16, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
CEO, President
1,000,000$0.69$688.4K1,391,776Jun 9, 2022Jun 13, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
200,000391,776Jan 24, 2022Jan 26, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
400,000400,000Jan 24, 2022Jan 26, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
300,000300,000Nov 4, 2021Nov 5, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
162,500162,500Apr 1, 2021Apr 2, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
525,000525,000Jan 27, 2021Jan 28, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
650,000650,000Feb 6, 2020Feb 7, 2020View →
Other insiders · RIGL
Loading peer insiders…
About this filer
CIK 0001190279
ROLE
CEO, President
PRIMARY
RIGL
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001190279DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback